GT Houston Shareholder Charles Dunham IV and GT Washington, D.C. Associate Tyler Scandalios are serving as speakers for CLMA's Regulatory Changes and Quality Improvement Shared Interest Group (SIG) Committee's webinar on October 8. The topic Dunham and Scandalios are presenting on is titled, "FDA Oversight of LDTs: The Present and Future Regulatory Landscape." The webinar will provide an update on the current status of FDA oversight of laboratory developed tests (LDTs), insights on the pending legislation in Congress and proposed changes by the Biden Administration that may impact how LDTs and test kits are regulated by the FDA. This presentation will provide valuable insights to both independent and institutional laboratories seeking to understand strategic planning to optimize market success and maintain compliance.
You May Also Be Interested In: